Homatropine
From Wikipedia, the free encyclopedia
Image:Homatropine.png | |
Homatropine
|
|
Systematic (IUPAC) name | |
(8,8-dimethyl-8-azoniabicyclo[3.2.1]oct-3-yl) 2-hydroxy-2-phenyl-acetate bromide | |
Identifiers | |
CAS number | 80-49-9 |
ATC code | A02BX03 |
PubChem | 6646 |
DrugBank | APRD01017 |
Chemical data | |
Formula | C17H24BrNO3 |
Mol. weight | 370.28 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Homatropine (Equipin®, Isopto Homatropine®) is an anticholinergic medication that inhibits muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, to temporarily paralyze accommodation, and as a mydriatic, to dilate the pupil.
Homatropine is less potent than atropine and has a shorter duration of action. It is available as the hydrobromide or methylbromide salt
[edit] Side effects
- Blurred vision
- Sensitivity to light
[edit] Contraindications
- Untreated glaucoma
- Myasthenia gravis
- Severe heart failure
- Thyrotoxicosis